Business Description
Eli Lilly and Co
NAICS : 325412
SIC : 2834
ISIN : BRLILYBDR006
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.17 | |||||
Debt-to-Equity | 2.34 | |||||
Debt-to-EBITDA | 2.94 | |||||
Interest Coverage | 22.68 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 9.45 | |||||
Beneish M-Score | -1.88 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | -1 | |||||
3-Year EPS without NRI Growth Rate | 0.8 | |||||
3-Year Book Growth Rate | 24.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 50.68 | |||||
Future 3-5Y Total Revenue Growth Rate | 19.77 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.47 | |||||
9-Day RSI | 57.78 | |||||
14-Day RSI | 58.06 | |||||
6-1 Month Momentum % | 37.21 | |||||
12-1 Month Momentum % | 116.36 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 250.76 | |||||
Days Sales Outstanding | 83.85 | |||||
Days Payable | 118.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.5 | |||||
Dividend Payout Ratio | 0.47 | |||||
3-Year Dividend Growth Rate | 15.2 | |||||
Forward Dividend Yield % | 0.47 | |||||
5-Year Yield-on-Cost % | 1.01 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 0.1 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.25 | |||||
Operating Margin % | 32.29 | |||||
Net Margin % | 15.36 | |||||
FCF Margin % | -9.01 | |||||
ROE % | 47.73 | |||||
ROA % | 9.38 | |||||
ROIC % | 21.84 | |||||
ROC (Joel Greenblatt) % | 61.86 | |||||
ROCE % | 19.77 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 136.86 | |||||
Forward PE Ratio | 62.11 | |||||
PE Ratio without NRI | 88.3 | |||||
Shiller PE Ratio | 154.01 | |||||
PEG Ratio | 8.25 | |||||
PS Ratio | 20.58 | |||||
PB Ratio | 68.59 | |||||
Price-to-Operating-Cash-Flow | 165.43 | |||||
EV-to-EBIT | 108.25 | |||||
EV-to-Forward-EBIT | 56.42 | |||||
EV-to-EBITDA | 88.96 | |||||
EV-to-Forward-EBITDA | 51.28 | |||||
EV-to-Revenue | 22.34 | |||||
EV-to-Forward-Revenue | 18.34 | |||||
EV-to-FCF | -241.8 | |||||
Price-to-Projected-FCF | 13.34 | |||||
Price-to-Median-PS-Value | 3.85 | |||||
Price-to-Peter-Lynch-Fair-Value | 8.24 | |||||
Earnings Yield (Greenblatt) % | 0.92 | |||||
FCF Yield % | -0.43 | |||||
Forward Rate of Return (Yacktman) % | 11.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Eli Lilly and Co Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil R$) | 169,336.821 | ||
EPS (TTM) (R$) | 0.941 | ||
Beta | -0.52 | ||
Volatility % | 33.9 | ||
14-Day RSI | 58.06 | ||
14-Day ATR (R$) | 3.08262 | ||
20-Day SMA (R$) | 127.4865 | ||
12-1 Month Momentum % | 116.36 | ||
52-Week Range (R$) | 57.4 - 132.59 | ||
Shares Outstanding (Mil) | 28,522.98 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Eli Lilly and Co Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Eli Lilly and Co Stock Events
Event | Date | Price(R$) | ||
---|---|---|---|---|
No Event Data |
Eli Lilly and Co Frequently Asked Questions
What is Eli Lilly and Co(BSP:LILY34)'s stock price today?
When is next earnings date of Eli Lilly and Co(BSP:LILY34)?
Does Eli Lilly and Co(BSP:LILY34) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |